HC Wainwright & Co. : The Metagenomi (MGX.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $10.00.

HC Wainwright & Co. : The Metagenomi (MGX.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $10.00.

Zhitong FinanceMay 15 23:11

HC Wainwright & Co. Reiterates Buy on Metagenomi, Maintains $10 Price Target

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Metagenomi (NASDAQ:MGX) with a Buy and maintains $10 price target.

BenzingaMay 15 23:09

Metagenomi Q1 2024 Adj EPS $(1.19) Misses $(0.78) Estimate

Metagenomi (NASDAQ:MGX) reported quarterly losses of $(1.19) per share which missed the analyst consensus estimate of $(0.78) by 52.56 percent.

BenzingaMay 15 04:39

Metagenomi Technologies, LLC | 10-Q: Quarterly report

SEC announcementMay 15 04:13 · Announcements

Press Release: Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results

Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results Late breaking presentation at World Federation of Hemophilia (WFH) World Congress on investigational develo

Dow JonesMay 15 04:05

Metagenomi Initiated at Buy by HC Wainwright & Co.

Metagenomi Initiated at Buy by HC Wainwright & Co.

Dow JonesMay 7 18:20